๊ธฐ๋ณธ ์ •๋ณด
  • ์ œํ’ˆ๋ช… ::
  • ๋ถ„๋ฅ˜ :: ํ•ญ์ƒ์ œ > ๋‹จ๋ฐฑ ํ•ฉ์„ฑ ์–ต์ œ์ œ > Tetracyclines
  • ํŠน์ง• :: ๊ด‘๋ฒ”์œ„ ํ•ญ์ƒ์ œ. ์‹๋„์—ผ ์œ ๋ฐœ ๊ฐ€๋Šฅ.
  • ์ž„์ƒ ::
๊ด€๋ จ ๋ฌธ์„œ
  • Ch.30 ํ•ญ์ƒ์ œ-๋‹จ๋ฐฑํ•ฉ์„ฑ ์–ต์ œ์ œ (Protein Synthesis Inhibitors) : Tetracyclines (30S ์ž‘์šฉ)
    • demeclocycline, doxycycline , minocycline, tetracycline ๋“ฑ์ด ์žˆ๋‹ค.
    • ์„ธ๊ท  ๋ฆฌ๋ณด์†œ์˜ 30S subunit์— ๊ฐ€์—ญ์ ์œผ๋กœ ๊ฒฐํ•ฉํ•˜์—ฌ tRNA์™€ mRNA-๋ฆฌ๋ณด์†œ ๋ณตํ•ฉ์ฒด์˜ ๊ฒฐํ•ฉ์„ ์ฐจ๋‹จํ•จ์œผ๋กœ์จ ์„ธ๊ท ์˜ ๋‹จ๋ฐฑ์งˆ ํ•ฉ์„ฑ์„ ์–ต์ œํ•œ๋‹ค.
    • ๊ทธ๋žŒ ์–‘์„ฑ/์Œ์„ฑ ๋ฐ ๋‹ค์–‘ํ•œ ์ข…์„ ๋น„๋กฏํ•œ ๊ด‘๋ฒ”์œ„ํ•œ ์—ฌ๋Ÿฌ ์„ธ๊ท ์— ์ •๊ท ์ œ๋กœ ์ž‘์šฉํ•œ๋‹ค.
    • ๋ชจ๋“  tetracycline์€ ํƒœ๋ฐ˜ ์žฅ๋ฒฝ์„ ํ†ต๊ณผํ•  ์ˆ˜ ์žˆ๋‹ค. minocycline ๊ณผ doxycycline ์€ CSF ๋ถ„ํฌ๊ฐ€ ๊ฐ€๋Šฅํ•˜๋‹ค.
    • ๋ถ€์ž‘์šฉ์œผ๋กœ๋Š” ์œ„๋ถˆ์พŒ๊ฐ, ๋“œ๋ฌผ๊ฒŒ ๊ฐ„๋…์„ฑ, ๊ด‘๋…์„ฑ, ์ „์ •๊ธฐ๊ด€ ๋ฌธ์ œ^[์ฃผ๋กœ minocycline ์ด endolymph์— ์ถ•์ ๋˜์–ด ๋ฐœ์ƒ] ๋“ฑ์ด ์žˆ๋‹ค.
  • ์—ฐ๋‚ด1(A) - 15. ๋น„๊ฐ•์˜ ์งˆํ™˜, ์—ฐ๋‚ด1(B) - 21. ๊ธฐ๊ด€๊ณผ ๊ธฐ๊ด€์ง€ ์งˆํ™˜ : Chlamydophila์™€ Mycoplasma์— ์šฐ์„  ์‚ฌ์šฉ. ๊ณ ์–‘์ด์—์„œ ํ”ํžˆ ๋ฐœ์ƒํ•˜๋Š” ๋งŒ์„ฑ ๋น„์—ผ์— ๋Œ€ํ•ด ๊ด‘๋ฒ”์œ„ ํ•ญ์ƒ์ œ๋กœ ์‚ฌ์šฉ.
  • ๋‚จ๋‚ด1(B) - 09. Polyarthritis (IMPA) : ์น˜๋ฃŒ ์‹œ 1์„ ์œผ๋กœ PDS or NSAIDs์—๋‹ค doxycycline ํ•จ๊ป˜ ์ฒ˜๋ฐฉ.
  • ๊น€๋‚ด2(A) - 1.7 Acquired Esophageal Weakness : ์‹๋„์— ํก์ฐฉํ•˜์—ฌ ์‹๋„์—ผ์„ ์œ ๋ฐœํ•˜๋Š” ๊ฒƒ์ด ๋Œ€ํ‘œ์ ์ธ ๋ถ€์ž‘์šฉ. ๋ฐ˜๋“œ์‹œ ์•ž๋’ค๋กœ ๋ฌผ์„ ๋จน์ธ๋‹ค!! ๋ณดํ˜ธ์ž ์•ˆ๋‚ด ์ค‘์š”!